Pediatrics·Springfield, MA

UMass Chan - Baystate

Signal lift66%83%+17 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
223–258
p10 – p90
Sample N
1,191
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.8%
10 of 309 applicants
01Cohort funnelthis cycle
N = 1,191
Applied
1,191
100.0%
Invited
309
25.9%
Class size
10
0.8%
J-1 visaF-1 visaCategoricalPreliminary
Your fitUMass Chan - Baystate Program

Create a free profile to see your personalized fit

Get started
Contact
MS
Program Director
Molly H Senn-McNally, MD
Email director
EL
Program Coordinator
Erica M Lunden
Email coordinator
Training sites2 hospitals · Springfield
  • 1
    UMass Chan-Baystate
    Springfield, MA
    Primary
  • 2
    Shriners Hospitals for Children (Springfield)
    Springfield, MA
    Participant
Score rangesinvited cohort
USMLE Step 2 CK223258
180205230255280
COMLEX Level 2 CE436610
400500600700800
Interview rates
US MD
57%
US DO
56%
US IMG
18%
Non-US IMG
8%
Applicant origin
In-state
85%
Out-of-state
25%
Interview prepPediatrics
specialtyWhy pediatrics over internal medicine or family medicine?★ common
clinicalHow do you communicate with children of different ages?★ common
behavioralDescribe a time you had to navigate a difficult conversation with parents.
specialtyAre you considering a subspecialty?
clinicalHow do you handle child abuse situations?
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesPediatrics · 25-26
Save this program

Add UMass Chan - Baystate to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Pediatrics.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.